Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Subgroup Analysis from a Phase 2, Single-Arm Trial of the Oral PI3Kδ Inhibitor Linperlisib in Patients with Relapsed or Refractory Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 6145.

https://doi.org/10.1182/blood-2023-177820

Published: 2023

Journal Articles

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

Blood (2023) 142 (Supplement 1): 1677.

https://doi.org/10.1182/blood-2023-178710

Published: 2023

Journal Articles

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Jun Zhu, Yuqin Song, Ye Guo, Keshu Zhou, Wenyu Li, Yu Yang, Qingqing Cai, Zhao Wang, Haiyan Yang

Blood (2023) 142 (Supplement 1): 3089.

https://doi.org/10.1182/blood-2023-189675

Published: 2023

Journal Articles

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Blood (2023) 142 (Supplement 1): 6140.

https://doi.org/10.1182/blood-2023-180373

Published: 2023

Journal Articles

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Blood (2023) 141 (16): 1971–1981.

https://doi.org/10.1182/blood.2022017734

Published: 2023

Includes: Supplemental data

Journal Articles

Efficacy of Frontline Treatments for Newly Diagnosed Transplant-Ineligible Multiple Myeloma, a Network Meta-Analysis

Maggie Wong, Chen Wang, Cinnie Yentia Soekojo, Hung Chew Wong, Sanjay De Mel, Melissa Ooi, Miny Samuel, Yu Yang Soon, Wee Joo Chng

Blood (2022) 140 (Supplement 1): 4345–4346.

https://doi.org/10.1182/blood-2022-165849

Published: 2022

Journal Articles

Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Eunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Cinnie Yentia Soekojo, Melissa Ooi, Wee-Joo Chng, Sanjay De Mel

Blood (2021) 138 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2021-151644

Published: 2021

Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141752

Published: 2020

Journal Articles

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Hui-qiang Huang, MD PhD, Rong Tao, MD PhD, Liqun Zou, Hong Cen, MD PhD, Ye Guo, MD PhD, Yunhong Huang, MD PhD, Wenbin Qian, MD PhD, Liling Zhang, MD PhD, Hui Zhou, MD PhD, Yu Yang, MD PhD, Haiyan Yang, Dan Zhu, Teng Fang, PhD, Hangjun Dai, Yueling Wang, Jianxin Yang, MD PhD

Blood (2019) 134 (Supplement_1): 2833.

https://doi.org/10.1182/blood-2019-121865

Published: 2019

Journal Articles

Alpha Globin Gene Copy Number Is Associated with Kidney Disease Among Black Individuals

Amy Parker Ruhl, MD MPH, Neal Jeffries, PhD, Yu Yang, MD, Rakhi P. Naik, MD, Lydia H. Pecker, MD, Bryan T. Mott, PhD, Neil A. Zakai, MDMSc, Cheryl A. Winkler, PhD, Jeffrey B. Kopp, MD, Leslie A. Lange, PhD, Marguerite R. Irvin, PhD, Orlando M. Gutierrez, MD, Mary Cushman, MD, Hans C. Ackerman, MD DPhil, MSc

Blood (2019) 134 (Supplement_1): 2248.

https://doi.org/10.1182/blood-2019-121493

Published: 2019

Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 682.

https://doi.org/10.1182/blood-2018-99-117848

Published: 2018

Journal Articles

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Gao Yan, Hui-qiang Huang, MD PhD, Wang Xiaoxiao, Bai Bing, Pengfei Li, Hui Zhou, Zhi-gang Peng, Xiao-yan Ke, Kai-yang Ding, Yu Yang, MD, Sha-dong Min, Yue-rong Shuang, Li Zhiming, Cai Qingqing, Bingzong Li, MDPhD, Wenqi Jiang

Blood (2018)

https://doi.org/10.1182/blood-2018-99-116551

Published: 2018

Journal Articles

Imprinted Non-Coding RNA Genes, H19 and ZNF215 , Are Potential Markers For Two-Year Survival For Acute Myeloid Leukemia Patients With Normal and Abnormal Karyotypes

Ming-Yu Yang, PhD, Jan-Gowth Chang, MD, I-Ya Chen, MS, Pai-Mei Lin, PhD, Hui-Hua Hsiao, MD, Yi-Chang Liu, MD, Wen-Chi Yang, MD, Sheng-Fung Lin, MD

Blood (2013) 122 (21): 2605.

https://doi.org/10.1182/blood.V122.21.2605.2605

Published: 2013

Journal Articles

Abolished Daily Expression Patterns of SIRT1 , SIRT2 , and SIRT5 in Human Chronic Myeloid Leukemia

Ming-Yu Yang, PhD, Pai-Mei Lin, PhD, Jui-Feng Hsu, MD, Wen-Chi Yang, MD, Yi-Chang Liu, MD, Hui-Hua Hsiao, MD, Chao-Sung Chang, MD, Cheng-Ming Hsu, MD, Sheng-Fung Lin, MD

Blood (2012) 120 (21): 4613.

https://doi.org/10.1182/blood.V120.21.4613.4613

Published: 2012

Journal Articles

Altered Regulation of Imprinted Non-Coding RNA Genes in Acute Myeloid Leukemia,

Ming-Yu Yang, PhD, Jan-Gowth Chang, MD, Pai-Mei Lin, PhD, Jui-Feng Hsu, MD, Cheng-Han Wu, MD, Wen-Chi Yang, MD, Yi-Chang Liu, MD, Hui-Hua Hsiao, MD, Sheng-Fung Lin, MD

Blood (2011) 118 (21): 3456.

https://doi.org/10.1182/blood.V118.21.3456.3456

Published: 2011

Journal Articles

Toll-Like Receptor 4 Mediates Heme Induced Acute Lung Injury: Preclinical Study of Resatorvid in Sickle Cell Disease

Samit Ghosh, PhD, Olufolake Adisa, MD, Yu Yang, Fang Tan, PhD, Solomon F Ofori-Acquah, PhD

Blood (2011) 118 (21): 2113.

https://doi.org/10.1182/blood.V118.21.2113.2113

Published: 2011

Journal Articles

Herpes Zoster Is Associated with An Increased Risk of Subsequent Lymphoid Malignancies — A Population-Based Matched-Control Study in Taiwan

Yi-Chang Liu, MD, Yi-Hsin Yang, PhD, Hui-Hua Hsiao, MD, Ming-Yu Yang, PhD, Wen-Chi Yang, MD, Sheng-Fung Lin, MD

Blood (2011) 118 (21): 1599.

https://doi.org/10.1182/blood.V118.21.1599.1599

Published: 2011

Journal Articles

Induction of Senescence by Doxorubicin Is Associated with Upregulated Mir-375 and Induction of Autophagy In CML Cell Line K562

Ming-Yu Yang, PhD, Wen-Chi Yang, MD, Pai-Mei Lin, PhD, Jui-Feng Hsu, MD, Hui-Hua Hsiao, MD, Yi-Chang Liu, MD, Hui-Jen Tsai, MD, Sheng-Fung Lin, MD

Blood (2010) 116 (21): 1843.

https://doi.org/10.1182/blood.V116.21.1843.1843

Published: 2010

Journal Articles

Regulation of Genes of the Circadian Clock In Human Chronic Myeloid Leukemia: Abolished Daily Oscillation of PER1 , PER2 , PER3 and CRY2.

Ming-Yu Yang, PhD, Wen-Chi Yang, MD, Pai-Mei Lin, PhD, Jui-Feng Hsu, MD, Hui-Hua Hsiao, MD, Yi-Chang Liu, MD, Hui-Jen Tsai, MD, Chao-Sung Chang, MD, Sheng-Fung Lin, MD

Blood (2010) 116 (21): 3633.

https://doi.org/10.1182/blood.V116.21.3633.3633

Published: 2010

Journal Articles

Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNγ/Stat1 signals

Yu Yang, Jordi C. Ochando, Jonathan S. Bromberg, Yaozhong Ding

Blood (2007) 110 (7): 2494–2500.

https://doi.org/10.1182/blood-2006-11-058271

Published: 2007

NARROW

Subgroup Analysis from a Phase 2, Single-Arm Trial of the Oral PI3Kδ Inhibitor Linperlisib in Patients with Relapsed or Refractory Follicular Lymphoma

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Efficacy of Frontline Treatments for Newly Diagnosed Transplant-Ineligible Multiple Myeloma, a Network Meta-Analysis

Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Alpha Globin Gene Copy Number Is Associated with Kidney Disease Among Black Individuals

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Imprinted Non-Coding RNA Genes, H19 and ZNF215 , Are Potential Markers For Two-Year Survival For Acute Myeloid Leukemia Patients With Normal and Abnormal Karyotypes

Abolished Daily Expression Patterns of SIRT1 , SIRT2 , and SIRT5 in Human Chronic Myeloid Leukemia

Altered Regulation of Imprinted Non-Coding RNA Genes in Acute Myeloid Leukemia,

Toll-Like Receptor 4 Mediates Heme Induced Acute Lung Injury: Preclinical Study of Resatorvid in Sickle Cell Disease

Herpes Zoster Is Associated with An Increased Risk of Subsequent Lymphoid Malignancies — A Population-Based Matched-Control Study in Taiwan

Induction of Senescence by Doxorubicin Is Associated with Upregulated Mir-375 and Induction of Autophagy In CML Cell Line K562

Regulation of Genes of the Circadian Clock In Human Chronic Myeloid Leukemia: Abolished Daily Oscillation of PER1 , PER2 , PER3 and CRY2.

Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNγ/Stat1 signals

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only